THC Farmaceuticals, Inc.
CBDG
$0.013
-$0.0011-7.80%
OTC PK
| 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | |
|---|---|---|---|---|---|
| Revenue | 18.50K | 18.40K | 18.50K | 19.10K | 18.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.50K | 18.40K | 18.50K | 19.10K | 18.90K |
| Cost of Revenue | 14.20K | 12.40K | 10.60K | 12.30K | 13.80K |
| Gross Profit | 4.30K | 6.00K | 7.90K | 6.80K | 5.10K |
| SG&A Expenses | 73.80K | 42.60K | 27.00K | 30.10K | 24.80K |
| Depreciation & Amortization | 900.00 | 900.00 | 700.00 | 700.00 | 700.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 88.70K | 55.70K | 38.20K | 43.10K | 39.30K |
| Operating Income | -70.20K | -37.30K | -19.80K | -24.10K | -20.50K |
| Income Before Tax | -72.60K | -41.20K | -25.00K | -30.70K | -26.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.07 | -0.04 | -0.03 | -0.03 | -0.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.60K | -41.20K | -25.00K | -30.70K | -26.50K |
| EBIT | -70.20K | -37.30K | -19.80K | -24.10K | -20.50K |
| EBITDA | -69.60K | -36.70K | -19.20K | -23.40K | -19.80K |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 50.91M | 44.88M | 44.88M | 41.88M | 41.88M |
| Average Diluted Shares Outstanding | 50.91M | 44.88M | 44.88M | 41.88M | 41.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |